"10.1371_journal.pone.0062250","plos one","2013-05-07T00:00:00Z","Matej Ošlaj; Jérôme Cluzeau; Damir Orkić; Gregor Kopitar; Peter Mrak; Zdenko Časar","Genetics, Anti-Infectives, Lek Pharmaceuticals d.d., Mengeš, Slovenia; API Development, Sandoz Development Center Slovenia, Lek Pharmaceuticals d.d., Mengeš, Slovenia; Faculty of Pharmacy, University of Ljubljana, Ljubljana, Slovenia","Conceived and designed the experiments: PM ZČ GK. Performed the experiments: MO JC. Analyzed the data: MO JC GK ZČ PM. Contributed reagents/materials/analysis tools: MO DO JC PM. Wrote the paper: PM ZČ.","This work was funded by Lek pharmaceuticals d.d., a Sandoz company. This does not alter the authors’ adherence to all the PLOS ONE policies on sharing data and materials. The authors of this work are employed by Lek pharmaceuticals d.d., a Sandoz company. The interests of this commercial funder are pursued through the patent applications: WO2008119810 and WO2009092702. The sole purpose of this work is to share the findings obtained during the development of the described process with the scientific community and the publication has no impact on any products; in development or marketed. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","2013","05","Matej Ošlaj","MO",6,TRUE,3,2,5,2,TRUE,TRUE,FALSE,0,NA,FALSE
